Chromene-Thiazole Derivatives as Potential SARS-CoV‑2 Mpro Inhibitors: Synthesis and Computational Studies
- ACS Omega. 2025 Dec 17;10(51):62757-62774. doi: 10.1021/acsomega.5c07593.
- 1. Department of Chemistry, Susquehanna University, 514 University Avenue, Selinsgrove, Pennsylvania 17870, United States.
- 2. Bioinformatics Multidisciplinary Environment, Programa de Pós Graduação em Bioinformática, Universidade Federal do Rio Grande do Norte, Natal 59078-400, RN, Brazil.
- 3. Departamento de Biofísica e Farmacologia, Universidade Federal do Rio Grande do Norte, 59072-970 Natal-RN, Brazil.
Three chromene-thiazole derivatives bearing benzimidazole, benzothiazole, and phenyl-1,2,4-triazole moieties were synthesized and evaluated for their potential as SARS-CoV-2 Mpro inhibitors. The derivatives were characterized by various spectroscopic and spectrometric methods: FT-IR, 1H NMR, 13C NMR, HRMS. Density functional theory (DFT) at the B3LYP/6-311++G-(3df,3pd) level was used to calculate the optimized structures of the derivatives and determine their electronic properties. Molecular docking analyses of the derivatives with SARS-CoV-2 Mpro (PDB ID: 6LU7) indicate significant interactions, with docking affinity scores ranging from -7.5 kcal/mol for the benzothiazole derivative to -8.4 kcal/mol for the phenyl-1,2,4-triazole derivative. These docking scores are comparable to or better than those of ML188 (-7.5 kcal/mol), a potent SARS-CoV-2 Mpro inhibitor, indicating the inhibitory potential of these derivatives. Molecular dynamics simulations and QM/MM calculations of the derivatives confirmed the stability of the protein-ligand interactions, and highlighted the key amino acid residues involved in stabilization.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Infection